@inproceedings{inproceedings, title  = {{DOC-MEK: A double-blind randomized phase II trial of docetaxel with or without selumetinib (AZD6244; ARRY-142886) in wt BRAF advanced melanoma}},

 url = {{}},

 year = {{2013}},

 month = {{5}},

 author = {{Gupta A and Love S and Schuh A and Collins L and Thomason A and Asher R and Lisle R and Churchman M and Shanyinde M and Plummer R and Nathan PD et al}},

 volume = {{31}},

 journal = {{JOURNAL OF CLINICAL ONCOLOGY}},

 issue = {{15}},

 note = {{Accessed on 2024/12/26}}}